Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurodegenerative diseases
Pharma
Congress's biotech report, NIH ban, GSK-ABL—Fierce Pharma Asia
A congressional committee released a report on the U.S.-China biotech rivalry. The NIH blocked China's access to some databases. And more.
Angus Liu
Apr 11, 2025 10:31am
Neurotech nabs first nod for eye disease cell therapy implant
Mar 10, 2025 9:50am
Zevra lines up $150M from sale of PRV tied to Miplyffa approval
Feb 27, 2025 9:58am
IntraBio snags FDA nod in rare disease just days after Zevra
Sep 25, 2024 9:50am
Zevra snags FDA approval for new lysosomal storage disorder med
Sep 20, 2024 1:54pm
Amylyx to pull failed ALS drug from market, cut 70% of staff
Apr 4, 2024 10:06am
